Dr Rudolf Giger

Dr Rudolf Giger

Dr Rudolf Giger
Since retiring from from Novartis Pharma AG, Rudolf has been offering consulting services as CEO of Giger MedChem Consulting, with expertise in medicinal chemistry, organic chemistry, synthetic chemistry, natural product chemistry, chemistry of drug metabolism and combinatorial chemistry. He is currently head of medicinal chemistry for Esperanza Medicines Foundation. He has a Ph.D. in organic chemistry from the Swiss Federal Institute of Technology, Zurich, and a post-doctorate at California Institute of Technology, Pasadena (CALTECH). His professional career in the pharmaceutical industry spans more than three decades and his achievements include the invention of the drug Tegaserod.

Comments are closed.